ChampionX Corp (CHX) concluded trading on Thursday at a closing price of $28.49, with 3.36 million shares of worth about $95.67 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 1.03% during that period and on March 13, 2025 the price saw a loss of about -0.49%. Currently the company’s common shares owned by public are about 190.70M shares, out of which, 188.24M shares are available for trading.
Stock saw a price change of -0.11% in past 5 days and over the past one month there was a price change of -4.07%. Year-to-date (YTD), CHX shares are showing a performance of 4.78% which decreased to -10.72% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $25.57 but also hit the highest price of $39.95 during that period. The average intraday trading volume for ChampionX Corp shares is 2.85 million. The stock is currently trading -2.43% below its 20-day simple moving average (SMA20), while that difference is down -1.64% for SMA50 and it goes to -6.35% lower than SMA200.
ChampionX Corp (NASDAQ: CHX) currently have 190.70M outstanding shares and institutions hold larger chunk of about 91.77% of that.
The stock has a current market capitalization of $5.44B and its 3Y-monthly beta is at 1.84. PE ratio of stock for trailing 12 months is 17.22, while it has posted earnings per share of $1.65 in the same period. It has Quick Ratio of 1.36 while making debt-to-equity ratio of 0.41. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for CHX, volatility over the week remained 3.66% while standing at 3.23% over the month.
Stock’s fiscal year EPS is expected to drop by -4.07% while it is estimated to increase by 9.60% in next year.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Piper Sandler on January 08, 2024 offering a Neutral rating for the stock and assigned a target price range of between $38 and $32 to it. Coverage by Barclays stated ChampionX Corp (CHX) stock as an Overweight in their note to investors on October 17, 2023, suggesting a price target of $42 for the stock. On July 14, 2023, CapitalOne Initiated their recommendations, while on October 06, 2022, Barclays Downgrade their ratings for the stock with a price target of $28. Stock get a Buy rating from The Benchmark Company on August 25, 2022.
